1 ANASTROZOLE | 130 of 2220 | 2950 prescriptions Less than 1% of all prescriptions | 2760 | 440 patients 22% of all patients | < 11 | |
2 LETROZOLE | 430 of 1840 | 1010 prescriptions Less than 1% of all prescriptions | | 150 patients 7% of all patients | < 11 | |
3 POTASSIUM CHLORIDE | 250 of 1280 | 420 prescriptions Less than 1% of all prescriptions | | 170 patients 8% of all patients | < 11 | |
4 HYDROXYUREA | 380 of 1450 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
5 IMATINIB MESYLATE | 30 of 700 | 570 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
6 TAMOXIFEN CITRATE | 600 of 1540 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 WARFARIN SODIUM | 430 of 1090 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 VENLAFAXINE HCL ER (VENLAFAXINE HCL) | 130 of 490 | 260 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
9 HYDROCODONE-ACETAMINOPHEN (HYDROCODONE/ACETAMINOPHEN) | 450 of 2460 | 770 prescriptions Less than 1% of all prescriptions | 520 | 260 patients 13% of all patients | < 11 | O |
10 EXEMESTANE | 300 of 1050 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
11 SERTRALINE HCL | 120 of 290 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
12 ANAGRELIDE HCL | 160 of 260 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 IBANDRONATE SODIUM | 80 of 100 | 190 prescriptions Less than 1% of all prescriptions | 190 | < 11 | < 11 | |
14 LEVOTHYROXINE SODIUM | 500 of 1180 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 PANTOPRAZOLE SODIUM | 340 of 1080 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 FUROSEMIDE | 270 of 740 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
17 OMEPRAZOLE | 200 of 660 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
18 GABAPENTIN | 490 of 1700 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
19 FENTANYL | 280 of 900 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
20 ALENDRONATE SODIUM | 240 of 630 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
21 TASIGNA (NILOTINIB HCL) | 40 of 220 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 ELIQUIS (APIXABAN) | 380 of 1120 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
23 MEGESTROL ACETATE | 190 of 480 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 XARELTO (RIVAROXABAN) | 630 of 1510 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 ESOMEPRAZOLE MAGNESIUM | 100 of 170 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
26 DULOXETINE HCL | 150 of 340 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
27 PREDNISONE | 610 of 1900 | 210 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 PROMETHAZINE HCL | 90 of 510 | 400 prescriptions Less than 1% of all prescriptions | | 230 patients 11% of all patients | < 11 | |
29 DEXAMETHASONE | 640 of 2110 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
30 REVLIMID (LENALIDOMIDE) | 590 of 1440 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
31 ALLOPURINOL | 270 of 530 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
32 ONDANSETRON ODT (ONDANSETRON) | 320 of 1160 | 250 prescriptions Less than 1% of all prescriptions | | 210 patients 10% of all patients | < 11 | |
33 TRAMADOL HCL | 330 of 1210 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | O |
34 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 150 of 290 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | A |
35 LEVOFLOXACIN | 280 of 840 | 160 prescriptions Less than 1% of all prescriptions | 160 | 110 patients 5% of all patients | 110 patients 5% of all patients | A |